Fisher Wallace Laboratories, Inc. — Regulation A 1-A POS

Fisher Wallace Laboratories, Inc. of BROOKLYN, NY filed a Regulation A 1-A POS with the SEC on 2023-05-05. Aggregate offering: $10.0M (Tier 2). Industry: Other.

Offering

Filed: 2023-05-05
Form: 1-A POS
Accession: 0001104659-23-056589
Tier: Tier 2
Total aggregate offering: $10.0M
Issuer portion: $10.0M
Price per security: $10.6700
Securities offered: Equity (common or preferred stock)
Broker-dealer CRD: 291773
Audit status: Audited
Auditor: IndigoSpire CPAs & Advisors
Jurisdictions: 104 states/territories

Issuer

CIK: 0001787792
Organized in: DE
Incorporated: 2019
Address: 630 FLUSHING AVENUE - BOX 84, BROOKLYN, NY, 11206
Phone: 800-692-4380
Employees: 4 full-time, 4 part-time

Financial snapshot (as filed)

Total assets: $439K
Cash & equivalents: $128K
Total liabilities: $4.7M
Stockholder equity: $-4.2M
Revenues: $473.9M
Net income: $3.6M

People (1)

Name	Role	Location
Jeffrey S. Marks	Signer	Newport Beach, CA

Other Reg A filings by this issuer (20)

Showing 15 of 20 filings.

Filed	Form
2026-04-30	1-K
2024-04-30	1-K
2023-06-06	1-A POS
2023-06-05	1-A POS
2023-05-01	1-K
2023-03-29	1-A POS
2023-02-23	1-A/A
2023-02-21	1-A/A
2023-02-17	1-A/A
2023-02-13	1-A/A
2023-01-31	1-A/A
2023-01-17	1-A
2023-01-11	1-A/A
2022-04-29	1-K
2021-04-28	1-K

More